Healthy volunteers help fine-tune aramchol dosing
NCT ID NCT07251712
First seen Jan 09, 2026 · Last updated May 23, 2026 · Updated 17 times
Summary
This early-stage study enrolls 32 healthy volunteers to measure how much aramchol gets into the blood from two different single doses of a new tablet form. The goal is to compare the drug levels and choose the best dose for future studies. Participants are healthy adults aged 18-55 with a normal body weight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hammersmith Medicines Research (HMR)
RECRUITINGLondon, NW10 7EW, United Kingdom
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.